CIK 0001479615 · Non-accelerated filer<br>Smaller reporting company
Silence Therapeutics plc
Sign in to watch- Tickers
- SLN SLNCF
- Exchange
- Nasdaq, OTC
- Industry
- Pharmaceutical Preparations
- Incorporated
- United Kingdom
- Entity type
- operating
- Phone
- 44-0-20-3457 6900
- Business address
- 12 HAMMERSMITH GROVE, OFFICE 205, LONDON, United Kingdom, W6 7AP
Securities
- SLN American Depository Share Nasdaq
- SLNCF Common stock OTC
- 424B5 Offering Prospectus
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- SC 13D/A Stake Beneficial Ownership Report
- SC 13D Stake Beneficial Ownership Report
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 6-K Event Report of Foreign Issuer
- 20-F Report Annual and Transition Report of Foreign Private Issuers
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13G/A Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
- SC 13G Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 6-K Event Report of Foreign Issuer
Page 10 of 14 · 278 filings